F2R and lung cancer: Serum PAR-1 concentrations of lung cancer patients were significantly increased as compared to controls (i.e. median values of 26.45 ng/mL and 0.07 ng/mL, respectively), but serum PAR-1 levels did not correlate with clinical variables and failed to predict prognosis of the lung cancer patients.